IMMUSMOL SAS has a total of 15 patent applications. Its first patent ever was published in 2013. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United Kingdom. Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are CHONGQING YUANLUN BIO TECHNOLOGY CO LTD, APROGEN KIC INC and SHRINERS HOSPITALS FOR CRIPPLE.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United Kingdom | 3 | |
#4 | United States | 3 | |
#5 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Measuring microorganism processes | |
#6 | Therapeutic chemical compounds | |
#7 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Bessède Alban | 8 |
#2 | Bessede Alban | 4 |
Publication | Filing date | Title |
---|---|---|
WO2016193499A1 | Immunomodulatory antibody or immunotherapeutic, agent which increases and/or mimicks kynurenine, and optional combination thereof | |
GB201511291D0 | Agent which increases and/or mimics Kynurenine and optional combination thereof with an immunotherapeutic | |
GB201413162D0 | Prediction of cancer treatment based on determination of enzymes or metabolites of the kynurenine pathway | |
WO2014056934A1 | Modulator of quinolinic acid for use in the treatment of a neuropathological disease | |
GB201322538D0 | Method for detecting small molecules in a sample | |
EP2864790A1 | Antagonist to an enzyme and/or a metabolite of the kynurenine pathway |